Patients with dermal fillers have a small potential risk of developing facial swelling after obtaining mRNA vaccines.
To date, the FDA has noted the problem in three clinical trial recipients of the COVID-19 vaccine from Moderna(NSDQ:MRNA). The agency hasn’t observed facial swelling in the Phase 3 clinical trial for the COVID-19 vaccine from Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX).
We reached out to Dr. Whitney Bowe, a board-certified dermatologist and expert injector, to shed light on the topic.
Get the full story form our sister site, Drug Discovery & Development.